Etsuko Okada

7PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 14, 2023
Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study.

Tetsuji Yanase, Noriko Tsuruta, Kazuki Yamaguchi

|Feb 25, 2022
Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis.

Ayaka Kaneoka, Etsuko Okada, Hitomi Sugino

|Jul 02, 2021
A Positive Dermcidin Expression Is an Unfavorable Prognostic Marker for Extramammary Paget's Disease.

Shun Ohmori, Yu Sawada, Natsuko Saito-Sasaki

|Jun 02, 2021
Cell Adhesion Molecule 1 (CADM1) Is an Independent Prognostic Factor in Patients with Cutaneous Squamous Cell Carcinoma.

Natsuko Saito-Sasaki, Yu Sawada, Etsuko Okada

Pageof 2